Byrnes Robert F Insider Trades

Insider Trading History

Track insider trading activity for Byrnes Robert F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $43.8k 12,000 shares
Last Trade
May 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 12,000 shares
$19.40
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $60.2k 16,500 shares
Last Trade
May 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 6,000 shares
$19.40
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $38.3k 10,500 shares
Last Trade
May 09, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.7k 4,500 shares
$12.82
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $32.9k 9,000 shares
Last Trade
May 09, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 9,000 shares
$12.82
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $21.9k 6,000 shares
Last Trade
May 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.5k 3,000 shares
$29.15
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $21.9k 6,000 shares
Last Trade
May 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 6,000 shares
$29.15
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $21.9k 6,000 shares
Last Trade
May 11, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 9,000 shares
$20.90
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $29.2k 8,000 shares
Last Trade
May 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 8,000 shares
$16.63
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2016 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$204k 10,999 shares
$18.58
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $49.9k 13,665 shares
Last Trade
Feb 24, 2016 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$204k 10,999 shares
$18.58
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $14.6k 4,000 shares
Last Trade
Feb 12, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68.4k 4,000 shares
$17.09
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 12, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68.4k 4,000 shares
$17.09
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 12, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$91.1k 5,333 shares
$17.09
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $40.1k 10,999 shares
Last Trade
Feb 12, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$91.1k 5,333 shares
$17.09
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $20.7k 5,666 shares
Last Trade
Feb 12, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.5k 1,666 shares
$17.09
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $29.2k 8,000 shares
Last Trade
May 07, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 8,000 shares
$20.42
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $9.73k 2,666 shares
Last Trade
Sep 17, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$57.5k 2,666 shares
$21.58
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Sep 17, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$57.5k 2,666 shares
$21.58
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Sep 17, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$57.5k 2,666 shares
$21.58
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $9.73k 2,666 shares
Last Trade
Sep 17, 2014 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$57.5k 2,666 shares
$21.58
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up